BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 27030075)

  • 1. Evaluation and management of pancreatic lesions in patients with von Hippel-Lindau disease.
    Keutgen XM; Hammel P; Choyke PL; Libutti SK; Jonasch E; Kebebew E
    Nat Rev Clin Oncol; 2016 Sep; 13(9):537-49. PubMed ID: 27030075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and treatment of pancreatic neuroendocrine neoplasmas in Von Hippel-Lindau syndrome].
    Liu WK; Tian XD; Yang YM
    Zhonghua Wai Ke Za Zhi; 2018 Nov; 56(11):869-872. PubMed ID: 30392308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of pancreatic neuroendocrine tumor in von Hippel-Lindau disease.
    Tamura K; Nishimori I; Ito T; Yamasaki I; Igarashi H; Shuin T
    World J Gastroenterol; 2010 Sep; 16(36):4515-8. PubMed ID: 20857520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of pancreatic involvement in von Hippel-Lindau disease: a retrospective study of 55 cases in a single center.
    Park TY; Lee SK; Park JS; Oh D; Song TJ; Park DH; Lee SS; Seo DW; Kim MH
    Scand J Gastroenterol; 2015 Mar; 50(3):360-7. PubMed ID: 25562111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gastroenterological manifestations of von Hippel-Lindau disease - a case report].
    Koniusz J; Dąbkowski K; Buczek K; Gomółka A; Starzyńska T
    Pol Merkur Lekarski; 2017 Aug; 43(254):66-68. PubMed ID: 28875972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease.
    Kitano M; Millo C; Rahbari R; Herscovitch P; Gesuwan K; Webb RC; Venkatesan AM; Phan GQ; Hughes MS; Libutti SK; Nilubol N; Linehan WM; Kebebew E
    Surgery; 2011 Dec; 150(6):1122-8. PubMed ID: 22136831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic lesions in von Hippel-Lindau disease? A systematic review and meta-synthesis of the literature.
    Charlesworth M; Verbeke CS; Falk GA; Walsh M; Smith AM; Morris-Stiff G
    J Gastrointest Surg; 2012 Jul; 16(7):1422-8. PubMed ID: 22370733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau.
    Hammel PR; Vilgrain V; Terris B; Penfornis A; Sauvanet A; Correas JM; Chauveau D; Balian A; Beigelman C; O'Toole D; Bernades P; Ruszniewski P; Richard S
    Gastroenterology; 2000 Oct; 119(4):1087-95. PubMed ID: 11040195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations.
    Libutti SK; Choyke PL; Bartlett DL; Vargas H; Walther M; Lubensky I; Glenn G; Linehan WM; Alexander HR
    Surgery; 1998 Dec; 124(6):1153-9. PubMed ID: 9854597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of tumor growth in pancreatic neuroendocrine tumors in von Hippel Lindau syndrome.
    Weisbrod AB; Kitano M; Thomas F; Williams D; Gulati N; Gesuwan K; Liu Y; Venzon D; Turkbey I; Choyke P; Yao J; Libutti SK; Nilubol N; Linehan WM; Kebebew E
    J Am Coll Surg; 2014 Feb; 218(2):163-9. PubMed ID: 24440063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic neuroendocrine tumours in patients with von Hippel-Lindau disease.
    Zwolak A; Świrska J; Tywanek E; Dudzińska M; Tarach JS; Matyjaszek-Matuszek B
    Endokrynol Pol; 2020; 71(3):256-259. PubMed ID: 32797472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential value of EUS in pancreatic surveillance of VHL patients.
    van Asselt SJ; Brouwers AH; van Dullemen HM; van der Jagt EJ; Bongaerts AH; Koopmans KP; Kema IP; Zonnenberg BA; Timmers HJ; de Herder WW; Sluiter WJ; de Vries EG; Links TP
    Eur J Endocrinol; 2016 May; 174(5):611-20. PubMed ID: 26884551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic neuroendocrine tumours.
    Alexakis N; Neoptolemos JP
    Best Pract Res Clin Gastroenterol; 2008; 22(1):183-205. PubMed ID: 18206821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of
    Shell J; Tirosh A; Millo C; Sadowski SM; Assadipour Y; Green P; Patel D; Nilubol N; Kebebew E
    Eur J Radiol; 2019 Mar; 112():130-135. PubMed ID: 30777201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease.
    Libutti SK; Choyke PL; Alexander HR; Glenn G; Bartlett DL; Zbar B; Lubensky I; McKee SA; Maher ER; Linehan WM; Walther MM
    Surgery; 2000 Dec; 128(6):1022-7;discussion 1027-8. PubMed ID: 11114638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Hippel-Lindau disease-associated solid microcystic serous adenomas masquerading as pancreatic neuroendocrine neoplasms.
    Turcotte S; Turkbey B; Barak S; Libutti SK; Alexander HR; Linehan WM; Hughes MS; Nilubol N; Gesuwan K; Millo C; Quezado M; Choyke PL; Kebebew E; Phan GQ
    Surgery; 2012 Dec; 152(6):1106-17. PubMed ID: 23107912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and management strategies for pNETs in Von Hippel-Lindau: a systematic review.
    Ahmad S; Naber MR; Giles RH; Valk GD; van Leeuwaarde RS
    Endocr Relat Cancer; 2021 Mar; 28(3):151-160. PubMed ID: 33512331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic organ-sparing resection of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors.
    von Dücker L; Walz MK; Voss C; Arnold G; Eng C; Neumann HP
    World J Surg; 2011 Mar; 35(3):563-7. PubMed ID: 21181474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors.
    Krauss T; Ferrara AM; Links TP; Wellner U; Bancos I; Kvachenyuk A; Villar Gómez de Las Heras K; Yukina MY; Petrov R; Bullivant G; von Duecker L; Jadhav S; Ploeckinger U; Welin S; Schalin-Jäntti C; Gimm O; Pfeifer M; Ngeow J; Hasse-Lazar K; Sansó G; Qi X; Ugurlu MU; Diaz RE; Wohllk N; Peczkowska M; Aberle J; Lourenço DM; Pereira MAA; Fragoso MCBV; Hoff AO; Almeida MQ; Violante AHD; Quidute ARP; Zhang Z; Recasens M; Díaz LR; Kunavisarut T; Wannachalee T; Sirinvaravong S; Jonasch E; Grozinsky-Glasberg S; Fraenkel M; Beltsevich D; Egorov VI; Bausch D; Schott M; Tiling N; Pennelli G; Zschiedrich S; Därr R; Ruf J; Denecke T; Link KH; Zovato S; von Dobschuetz E; Yaremchuk S; Amthauer H; Makay Ö; Patocs A; Walz MK; Huber TB; Seufert J; Hellman P; Kim RH; Kuchinskaya E; Schiavi F; Malinoc A; Reisch N; Jarzab B; Barontini M; Januszewicz A; Shah N; Young WF; Opocher G; Eng C; Neumann HPH; Bausch B
    Endocr Relat Cancer; 2018 Sep; 25(9):783-793. PubMed ID: 29748190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic involvement in Korean patients with von Hippel-Lindau disease.
    Lee KH; Lee JS; Kim BJ; Lee JK; Kim SH; Kim SH; Lee KT
    J Gastroenterol; 2009; 44(5):447-52. PubMed ID: 19333546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.